Biotechnology
New patent for Santen drug VERKAZIA – DrugPatentWatch
Copyright © DrugPatentWatch. Originally published in New patent for Santen drug VERKAZIA
Annual Drug Patent Expiration for VERKAZIA
Verkazia is a drug marketed by Santen and included in one NDA. It is available from a single supplier. There are six patents protecting this drug.
This drug has ninety-four patent family members in twenty-three countries.
The generic ingredient in VERKAZIA is cyclosporine. One registered supplier for this compound. Additional details are available on the cyclosporine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for Santen drug VERKAZIA
